Crescent Capital BDC (CCAP) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Net investment income for Q3 2024 was $0.64 per share ($23.5M), with net income per share at $0.41 and net asset value per share at $20.20 as of September 30, 2024.
Portfolio comprised 183 companies across 20 industries, with 90%+ in senior secured first lien and unitranche loans, and 97.4% of debt investments at floating rates.
Non-accruals were low at 1.7% of cost and 0.9% of fair value, below industry averages.
Regular and supplemental dividends declared for Q4 and Q3 2024, totaling $0.49 per share.
Net asset value per share remained stable, up 2.5% year-over-year.
Financial highlights
Total investment income for Q3 2024 was $51.6 million, up from $48.2 million in Q3 2023, driven by non-recurring income.
Net realized and unrealized losses for Q3 2024 were $(8.1) million, compared to a $0.9 million gain in Q3 2023.
Net expenses increased to $28.1 million, mainly due to higher average debt outstanding.
Debt-to-equity ratio was 1.15x, with asset coverage at 186%.
Weighted average yield on income-producing securities was 11.6% for Q3 2024.
Outlook and guidance
Management expects increased deal activity in 2025, supported by lower borrowing costs and post-election optimism.
Portfolio remains defensively positioned with strong liquidity: $37.8 million in cash and $317 million undrawn credit capacity.
Focus remains on private credit transactions and maintaining a diversified portfolio.
97%+ of debt investments are floating rate, providing protection in a changing rate environment.
Management is confident in delivering attractive risk-adjusted returns and consistent dividend coverage.
Latest events from Crescent Capital BDC
- Q4 net investment income covered the dividend, with NAV at $19.10 and a defensively positioned portfolio.CCAP
Q4 202526 Feb 2026 - Q2 2024 NII reached $0.59/share, NAV $20.30, with strong liquidity and stable credit.CCAP
Q2 20241 Feb 2026 - Q4 2024 featured lower NII, stable NAV, robust liquidity, and special dividends for 2025.CCAP
Q4 202424 Dec 2025 - Board urges ratification of Ernst & Young LLP as auditor, with 2024 fees totaling $841,150.CCAP
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the 2025 annual meeting agenda.CCAP
Proxy Filing2 Dec 2025 - Stockholders will vote virtually on director elections and auditor ratification, with strong board oversight.CCAP
Proxy Filing2 Dec 2025 - Net investment income and NAV per share fell, but dividends and portfolio quality remain strong.CCAP
Q1 202526 Nov 2025 - Q2 2025 delivered strong income, stable NAV, and a $20M share repurchase program.CCAP
Q2 202523 Nov 2025 - Net investment income steady at $0.46 per share; NAV and net income per share declined.CCAP
Q3 202517 Nov 2025